Cheikh 2018
Cheikh 2018
Cheikh 2018
To cite this article: Mohamed Cheikh, Omar Hammouda, Nawel Gaamouri, Tarak Driss, Karim
Chamari, Ridha Ben Cheikh, Mohamed Dogui & Nizar Souissi (2018): Melatonin ingestion after
exhaustive late-evening exercise improves sleep quality and quantity, and short-term performances
in teenage athletes, Chronobiology International, DOI: 10.1080/07420528.2018.1474891
CONTACT Omar Hammouda hammouda.o@u-parisnanterre.fr Research Center on Sport and Movement (Centre de Recherches sur le Sport et le
Mouvement, CeRSM), UPL, Univ Paris Nanterre, UFR STAPS, 200 avenue de la République, 92001, Nanterre, France
Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/icbi.
© 2018 Taylor & Francis Group, LLC
2 M. CHEIKH ET AL.
demands on the body. The attempt to balance school, nocturnal awakening and make sleep more difficult
family, friends and sports leaves little free time and (Morin et al. 1999). In the same way, Souissi et al.
keeps their daily schedules full. To meet these (2012) have shown that maximal aerobic exercise
demands, student athletes are often late to bed and performed later in the evening is “worse” than train-
early to rise, sacrificing valuable sleep time in the ing in the afternoon and might result in a markedly
process (Bradford and Fitzgerald 2015). In addition, poor subsequent sleep quality (disturbing and frag-
a plausible explanation for this could be the increased menting sleep) measured with polysomnography
screen time (i.e. televisions, laptops, tablets, smart (PSG). Nevertheless, some previous studies found no
phones, eReaders, etc.) and social media use (Cain impairment in sleep following 1–3 h of vigorous
and Gradisar 2010). In the same way, Harbard et al. exercise ending 30 min before bedtime (O’Connor
(2016) demonstrated that chronotype may exert et al. 1998; Youngstedt et al. 1999). These studies
stronger influences on sleep timing than pre-bedtime have used either actigraphic or subjective methods.
activities. Indeed, most teenagers have internal clock A more recent study using PSG showed that vigorous
mechanisms predisposing them to become “night late-night exercise does not disturb sleep quality but
owls” (Reading 2013). Furthermore, it must be affect cardiac autonomic activity in the first sleep
noted that there is a problem of sleep initiation and hours (Myllymäki et al. 2011). A possible explanation
maintenance in 15–25% of children and adolescents of these discrepancies is that none of the previous
(Shamseer and Vohra 2009). Consequently, many studies examined the inter-individual variability in
teenagers are often in sleep deprivation. Even though, sleep behavior or the athletes’ chronotype (Vitale
adolescents still require 8–10 hours of sleep per night et al. 2017) and sleep assessment methods are
(National Sleep Foundation 2015), the sleep-average different.
time is of 6 h, 6 min (Tavernier et al. 2016). These However, objective and reliable data on this
findings could be attributable to decreased melatonin relationship are scarce, particularly for adolescents
(MEL) secretion – a key hormone of the circadian for whom studying sleep is challenging.
clock which facilitates sleep onset – associated to Still, sleep is required for optimal athletic per-
adolescence (Cavallo 1992). Indeed, the lowest rates formance and recovery, cognitive/academic per-
of plasma MEL are recorded during puberty (i.e. formance and well-being, together with reducing
116.6 ± 43.6 pg/ml against 153.6 ± 72.6 pg/ml before injury and illness risk within athletes, including
puberty) (Cavallo 1992). adolescents (Taylor et al. 2016). Practitioners and
Sleep is a restorative circadian process under- clinicians are thus under increasing pressure to
pinned by numerous interrelated biological processes encourage sufficient sleep in their athletes, since
(Vyazovskiy and Delogu 2014). Sleep has been attrib- inadequate sleep has been reported to reduce var-
uted to having an essential role in human health, vital ious physical performance measures (Thun et al.
for physical and cognitive performance and well- 2015). Specifically, reduced and/or disturbed sleep
being (Simpson et al. 2016). The importance of ade- has been shown to negatively influence aerobic
quate sleep for psychophysiological well-being is (Oliver et al. 2009) and anaerobic performance
emerged when sleep is disturbed (Myllymäki et al. metrics (Souissi et al. 2013).
2011). Even though physical activity is an effective Undeniably, among the few drugs designed to
non-pharmacological approach to improve sleep treat insomnia in adolescent, only MEL is considered
quality (Lang et al. 2013), vigorous late-night exercise safe and effective for use, at least, in short time
is mentioned by the American Academy of Sleep (Babineau et al. 2008) and without any risk of depen-
Medicine (2001) as one possible practice that may dency (Community Pediatrics Committee 2012).
produce increased arousal (reported already by Indeed, Scheer et al. (2012) showed that MEL had
Hauri (1968)) and leads to inadequate sleep hygiene no adverse effects on the athletes’ general health
(Myllymäki et al. 2011). Likewise, it has been demon- complaints as determined through a questionnaire
strated that evening intense physical exercise blunted inquiring about the presence or absence of headache,
MEL secretion due to exercise-induced cortisol insomnia, hyperactivity, irritability, nausea, “sleep-
increase (Monteleone et al. 1992). Most previous stu- ing limbs,” dizziness, constipation, “shaky hands,”
dies have shown that intense exercise may increase stomach cramp, drowsiness, sweating, hunger,
CHRONOBIOLOGY INTERNATIONAL 3
weakness and sore eyes. Another retrospective study Materials and methods
described the effects of long-term treatment with
Participants
MEL in adolescents (age range: 10–18 years) with
delayed sleep phase syndrome (Szeinberg et al. Ten male adolescent national-level judo competitors
2006). Patients were treated with oral MEL, (age: 15.4 ± 0.3 years; body mass: 60.68 ± 5.7 kg;
3–5 mg/day for an average period of 6 months (per- height: 167.9 ± 6.9 cm; BMI: 21.21 ± 2.5;
iod ranging from 1 to 16 months). No adverse effects mean ± SD) volunteered to take part in the study.
of MEL were noted (Szeinberg et al. 2006). A pediatrician determined all boys as pubertal stage
In some individuals, when used pharmacologi- (at the fifth Tanner stage) using the composite score
cally, the administration of physiologic doses (0.1– of the pubertal stage assessment (Tanner and
0.3 mg) of MEL decreases sleep onset latency Whitehouse 1976) and checked their health status.
(SOL), increases sleep efficiency (SE) and Two criteria were chosen so as to obtain a homo-
improves total sleep time (TST) (Zhdanova and genous group: First, their sleep/wake rhythm as well
Wurtman 1997; Brzezinski 1997). For the treat- as the quality and average amount of their sleep.
ment of the phase delay syndrome, the usual Indeed, the selected participants were either “neither
doses of MEL are 2.5 mg to 3 mg in children and type” (n = 7) or “moderately morning type” (n = 3)
5 mg to 10 mg in adolescents (Owens 2009). according to their answers to the Horne and
Among adolescents, the selected time of MEL Ostberg’s (1976) questionnaire (only neither type
administration should give a sleep time more com- or moderately morning type chronotype partici-
patible with normal school or social life (Dahlitz pants were involved in order to avoid any late
et al. 1991). This clock adjustment allows for nor- sleep onset and/or morning discomfort to wake-up
mal sleep quality and quantity and even a sleep and participate to the experiments). Their average
latency decrease and improved sleep quality and sleep duration evaluated over one month through a
TST (Zhdanova and Wurtman 1997). sleep schedule (Bastuji and Jouvet 1985) was about
Nevertheless, the results from the literature are 7 h (483 min±18.03). Second, their health status:
controversial and this could be explained by the The participants reported that they were non-smo-
different MEL doses used, the nature of supple- kers, not using anti-inflammatory neither antioxi-
mentation (acute or chronic), the time-of-day of dant agents, and did not report any history of
supplementation and/or the protocol setup. In cardiovascular or metabolic disorders. They were
recent years, there has been a great deal of interest currently training ~8 h/week. Participants and
in the possible role of MEL in improving physical their parents/tutors were fully informed of the pro-
performance and exercise-induced oxidative stress cedures and signed a consent form before partici-
and inflammatory responses (Beck et al. 2015). pating. The experimental design of the present study
To the best of the authors’ knowledge, the inter- was approved by the University’s Ethic Committee
action between (1) late-evening strenuous exercises, and met the ethical standards of the Declaration of
(2) nocturnal MEL ingestion, (3) sleep physiology Helsinki.
and (4) cognitive and short-term physical perfor-
mances the following morning in adolescents has
Experimental design
not been studied. Therefore, the purpose of this
study was to explore the effects of a single dose of Participants performed two test sessions. In each
MEL-10 mg ingestion after late-evening intensive session, they completed the Yo-Yo intermittent-
exercise on sleep quality and quantity, cognitive per- recovery-test level-1 (YYIRT-1) at ~20:00 h (time
formance and short-term physical performances the slot: 20:00 h to 20:45 h). The covered distance,
following morning in healthy trained teenagers. We peak heart rate (HRpeak) and rating of perceived
hypothesized that the present study’s findings would exertion (RPE) (Borg 1982) were recorded during
suggest that a single dose of MEL-10 mg ingestion the YYIRT-1. After the post-test shower (warm
after late-evening intensive exercise could promote water shower within 30 min from the end of the
sleep quality and quantity and improve morning exercise), participants took a standard dinner at
short-term performances in teenage athletes. 21:15 min. Then, sleep PSG was recorded from
4 M. CHEIKH ET AL.
22:15 min to 07:00 h, after the ingestion (i.e. recorded each 5 s) and only HRpeak was presented
22:00 h) of either a single tablet of MEL-10 mg in the data.
(vegetable source, made by Jamieson lab Toronto,
Montreal, Vancouver, Canada N8W5B5) or a Rating of perceived exertion scale (RPE)
Placebo (PLA) (made from starch and cellulose The RPE scale allows participants to give a sub-
in the laboratory of the local faculty of pharmacy) jective exertion rating for the physical task per-
in a double blind randomized order. Jamieson formed. It consists in a 15-point scale ranging
MEL-10 mg double action sustained release is an from 6 (very, very light) to 20 (very, very hard).
extended-release formula for two-stage sleep aid. The RPE scale is a reliable indicator of physical
The first layer dissolves rapidly to promote sleep, discomfort, has sound psychometric properties
while the second layer releases gradually the addi- and is strongly correlated with several other phy-
tional MEL to assure a complete night of restful siological measures of exertion (Borg 1982).
sleep. Participants were allowed to go to bed (at
22:15 min) in a quiet darkened room and at an Polysomnography
ambient temperature of 23°C. In the following Sleep recording was carried out using a portable
morning, the participants were awakened at polysomnographic machine (Track it MK3 – EEG/
07:00 h by an alarm clock and the PSG electrodes Polygraphy Recorder, USA) (https://www.lifelines
were removed. Upon doing their toilet and just neuro.com/.). PSG is a sleep study. This test
before taking their breakfast (i.e. 07:30 min), they records certain body functions during sleep, or
performed two cognitive tasks: i.e. the Choice attempts to sleep. PSG is used to diagnose sleep
Reaction Time (CRT) followed after 10 min by disorders. To perform the PSG recording, several
the one model Zazzo test, and the Hooper wellness electrodes were placed on the chin, scalp and the
index was collected. Then, participants completed outer edge of the eyelids of the participant (i.e. 8
the YYIRT-1, the Hand grip strength test (HG), electroencephalogram (EEG): for brain electrical
the five-jump test (5-JT) and the vertical and hor- activity; 4 electrooculogram (EOG): for horizontal
izontal Jump tests (VJ; HJ). Finally, the PSG device and vertical movements; 4 electromyogram
was taken to the hospital for blind encryption of (EMG): for chin muscular activity). EEG, EMG
the data by the specialized technician. and EOG were continuously recorded. PSG
recording was analyzed using the Polysmith’ soft-
ware allowing determining TST, Sleep cycles and
Exercises testing
stages composition (N1-, N2-, N3-sleep and rapid-
The Yo-Yo intermittent recovery test level-1 (YYIRT-1) eye-movement-sleep (REM-sleep)), SE (which is
The YYIRT-1 consisted of 20-m shuttle runs per- the ratio of the TST on the total time spent in
formed at increasing velocities with 10 s of active bed (TIB)), SOL and nocturnal awakening after
recovery between runs until exhaustion (Krustrup sleep onset (NA).
et al. 2003). Audio cues of the YYIRT-1 were
recorded on a CD (http://www.teknosport.com, The choice reaction-time test (CRT)
Ancona, Italy) and broadcasted using a calibrated CRT tests general alertness and motor speed. It
portable CD player (Philips, Az1030 CD player, is a 2-CRT test, stimulus and response uncer-
Eindhoven, Holland). The end of the test was tainty are introduced by having two possible
considered when the participant twice failed to stimuli and two possible responses. This is a
reach the front line on time (i.e. objective evalua- test to see how fast you can make a choice.
tion) or he felt unable to complete another shuttle You view a computer screen (15ʺ LCD) showing
at the dictated speed (i.e. subjective evaluation). a white square, a yellow or blue box will appear.
The total distance covered during the YYIRT-1 You must press the correct key on the computer
(including the last incomplete shuttle) was consid- (using the React! V0.9 software) as quickly and
ered as the test score. HR was recorded during the accurately as possible with the index finger when
YYIRT-1, using a Polar heart rate monitor (Polar you see the box. If the box is yellow you press Z,
Electro Oy, T61-coded, Hungary, with values X or C. If the box is blue you press B, N, or M.
CHRONOBIOLOGY INTERNATIONAL 5
You get 10 attempts in which the visual stimulus separately before testing sessions. Participants
occurred at random intervals of 1–10 s. Once the were asked to rate subjective quality of prior
10 attempts have been completed, the average of night-sleep and fatigue, stress and soreness muscle
the performances performed is displayed on the on a scale of 1–7.
computer screen and will be considered as the
Reaction Time (RT) scores (De Quel et al. 2015; Hand-grip strength (HG)
Bleeker et al. 1987). The maximal hand-grip strength of the dominant
hand was measured with a calibrated hand dynam-
The Zazzo test (1969) ometer (T.K.K. 5401; Takei, Tokyo, Japan). The
The Zazzo test aims at measuring the selective participants stood comfortably with their
attention. The test consisted in identifying a parti- shoulders adducted. The dynamometer was held
cular sign (a small square with a slash down to 45° freely without support and did not touch the par-
on the right), and crossing out as much as possible ticipant’s trunk. The position of the hand
in a limited time (10 min), working line by line, remained constant with a downward direction,
from left to right, leaving aside all the other signs and the palm did not flex on the wrist joint. The
whose orientation of the bar is different (Zazzo participants were required to exert maximal
1969). On each sheet of paper are 1000 signs strength on the dynamometer. They performed
represented and divided into 40 lines and 25 col- two trials, 1 min between each, the better perfor-
umns. Two types of errors can be identified: either mance being used for further analysis.
the participant bars a sign that is not identical to
those displayed on the board (additions: A) or he Five-jump test (5-JT)
forgets to bar (omissions: Om). The number of The 5-JT consists of five consecutive strides with
signs to cross out is 83. The results of the Zazzo joined feet position at the start and end of the
tests were analyzed based on the techniques of jumps to estimate lower body power. From the
computation and reading as described in the starting joined feet position, participants had to
Manual for the Psychological Examination of the directly jump to the front with a leg of their
Child (Zazzo 1969). choice. After the first four strides, i.e. alternating
left and right feet for twice each, they had to per-
● The inaccuracy in crossing out a sign = (Om form the last stride and end the test again with
+ A)/(number of signs to crossing out + A). joined feet. Performance was measured with a tape
● The speed of crossing out a sign. That is to say, measure from the front edge of the participant’s
the number of signs considered at the min- feet at the starting position to the rear edge of the
ute = number of signs considered × 60/time feet at the final position. The reliability of 5-JT
(seconds). performance has previously been assessed
● The performance of crossing out a sign = the (Chamari et al. 2008).
number of signs crossed out correctly in
10 min. Performance = (number of signs Vertical jump (VJ)
found × 10)/time (minutes). The participant must jump on the spot, arms
raised, along a wall. It is placed in the flexed leg
position – Knee joint 90°. Without gaining
The Hooper index momentum – it must not be lowered – it performs
The well-being/wellness Hooper index (Hooper a maximum thrust upward. The height at the jump
and Mackinnon 1995) based on ratings relative is measured by measuring the distance between
to fatigue, stress level, muscle soreness and sleep the start mark (upright arm) and the highest
quality/disorders has been suggested as one of the point reached by the hand. The test is considered
most cost-effective strategies for prevention and correct only when the participant falls to the same
early detection of nonfunctional overreaching. place. The vertical jump corresponds to the differ-
This method is the summation of these four sub- ence between the heights reached without jumping
jective ratings. Each of these ratings was measured and with jumping (Young 1995).
6 M. CHEIKH ET AL.
Results
RPE, HRpeak and the YYIRT-1 performance
YYIRT-1 test performed in the evening displayed no
significant difference between MEL and PLA
(p > 0.05) (Figure 1). Morning performances’ statis-
tical analysis showed a significantly higher YYIRT-1
performance with MEL compared to PLA (Δ = 82 m; Figure 1. Mean values ± ES of the distance (m) covered in the
p < 0.001; ES = −0.59) (Figure 1). Moreover, RPE YYIRT-1 recorded in the late-evening (20:00 h) and in the
morning (08:00 h) after nighttime either MEL-10 mg or PLA
scores after the YYIRT-1 test has indicated a signifi-
ingestion. ***: significant difference between MEL and PLA at
cant decrease in the MEL condition in comparison level p < 0.001. +++: significant difference between morning
with PLA one (Δ = −2.7; p < 0.001; ES = 2.55). and late-evening sessions at level p < 0.001.
CHRONOBIOLOGY INTERNATIONAL 7
Table 1. HRpeak during the YYIRT-1 test and RPE scores recorded in the late-evening (20:00 h) and in the morning (08:00 h) for PLA
and MEL conditions.
PLA MEL t value p value Δ value IC 95% ES
Late -Evening HRpeak (beats min−1) 193.60 ± 2.50 193.90 ± 2.30 −0.75 p > 0.05 0.30 [−0.38 to 1.25] −0.12
RPE (AU) 15.60 ± 0.80 15.70 ± 1.10 −0.36 p > 0.05 0.10 [−0.526 to 0.72] −0.10
Morning HRpeak (beats min−1) 190.40 ± 2.75 191.30 ± 1.34 −1.33 p > 0.05 0.9 [−0.62 to 2.42] −0.88
RPE (AU) 17.8 ± 0.92 15.1 ± 1.20 12.65 p < 0.001 −2.7 [−3.18 to 2.22] 2.55
PLA: placebo; MEL: melatonin; IC 95%: Confidence interval; ES: effect size; Δ = value MEL session–value PLA session; HRpeak: peak heart rate; RPE:
Rating of perceived exertion; AU: Arbitrary units.
Table 2. Sleep polysomnographic parameters (mean ± SD) (n = 10) recorded after nocturnal MEL or PLA ingestion.
Parameters PLA MEL Δ value IC 95% Δ% value t value p value ES
TIB (min) 518.0 ± 3.77 519.5 ± 4.03 1.50 [−0.38 to 3.38] 0.29 t = 1.80 p > 0.05 −0.38
TST (min) 463.0 ± 6.49 487.55 ± 6.98 24.55 [20.41 to 28.68] 5.30 t = 13.43 p < 0.001 −3.64
SE (%) 89.38 ± 1.07 93.85 ± 1.17 4.47 [3.75 to 5.18] 4.99 t = 14.07 p < 0.001 −3.99
SOL (min) 22.05 ± 4.17 13.60 ± 3.25 −8.45 [−11.2 to −5.65] −38.32 t = 6.81 p < 0.001 2.27
NA (min) 29.95 ± 7.58 18.95 ± 5.03 −11.00 [−14.18 to −7.82] −36.73 t = 7.82 p < 0.001 1.73
N1 sleep (%) 5.30 ± 1.38 3.52 ± 1.74 −1.78 [−2.33 to −1.23] −33.63 t = 7.38 p < 0.001 1.14
N2 sleep (%) 59.81 ± 3.55 57.91 ± 2.39 −1.90 [−3.68 to −0.12] −3.18 t = 2.42 p < 0.05 0.60
N3 sleep (%) 18.30 ± 3.04 19.86 ± 2.30 1.73 [0.18 to 3.27] 9.53 t = 2.53 p < 0.05 −0.58
REM sleep (%) 16.57 ± 1.95 18.72 ± 1.55 2.15 [1.12 to 3.18] 13.00 t = 4.72 p < 0.001 −1.22
TIB : time in bed; TST : total sleep time; SE : sleep-efficiency; SOL : sleep onset-latency; NA : total time of nocturnal awakenings after sleep onset; N1-
sleep : stage 1 sleep; N2-sleep : stage 2 sleep; N3-sleep : stage 3 sleep; REM-sleep : rapid-eye-movement-sleep; Δ = value MEL session–value PLA
session; Δ% = (Δ/value PLA session)×100; IC 95%: Confidence interval; ES: effect size; PLA: placebo; MEL: melatonin.
Table 3. Mean ± SD values for the cognitive performances and Hooper index (n = 10) measured the following morning after
nocturnal MEL or PLA ingestion.
Items PLA MEL Δ value IC 95% Δ% value t value p value ES
CRT (S) 0.42 ± 0.07 0.37 ± 0.06 −0.057 [−0.09 to −0.02] −13.47 3.63 p < 0.01 0.70
Zazzo Test Inaccuracy (AU) 0.05 ± 0.03 0.04 ± 0.04 −0.01 [−0.015 to 0.04] −21.82 1.03 p > 0.05 0.20
Speed (AU) 210.32 ± 51.35 265.95 ± 42.69 55.62 [0.22 to 111.03] 26.45 2.27 p < 0.05 −1.17
Performance (AU) 166.80 ± 43.50 208.31 ± 20.30 41.51 [11.31 to 71.71] 24.88 3.11 p < 0.05 −1.30
Hooper wellness index Sleep (AU) 3.60 ± 0.96 2.30 ± 0.94 −1.30 [−2.47 to −0.13] −36.11 2.51 p < 0.05 1.36
Fatigue (AU) 3.30 ± 0.94 2.30 ± 0.82 −1.00 [−1.75 to −0.24] −30.30 3.00 p < 0.05 1.09
Muscles soreness (AU) 3.30 ± 1.60 2.00 ± 0.94 −1.30 [−2.19 to 0.40] −39.39 3.28 p < 0.01 0.51
Stress (AU) 2.00 ± 0.94 1.90 ± 0.99 −0.10 [−1.14 to 0.94] −5.00 0.22 p > 0.05 0.10
CRT: Choice reaction time; Δ = MEL session value–PLA session value; Δ% = (Δ/PLA session value)×100. IC 95%: confidence interval; ES: Effect size;
PLA: Placebo; MEL: Melatonin; AU: Arbitrary units.
but it displayed a significant main positive effect of during MEL condition (p < 0.05). In contrast,
MEL ingestion on Speed (p < 0.05) and stress level was unchanged when comparing both
Performance (p < 0.05). Nevertheless, results conditions (p > 0.05).
showed reduced selective attention with PLA com-
pared to MEL.
Short-term physical performances
The Hooper index Data related to the short-term physical perfor-
Data related to the Hooper index are presented in mances are presented in Table 4. There was no
Table 3. Statistical analysis of data collected from significant difference between PLA and MEL con-
the four subjective ratings demonstrated that the ditions in HG performance (p > 0.05). Statistical
feeling of fatigue and muscle soreness were lower analysis revealed significant increase in 5-JT per-
the morning after MEL ingestion compared with formance with MEL when compared to PLA
PLA (p < 0.05 and p < 0.01, respectively). Likewise, (p < 0.05) (Figure 2). The performance during
a significant effect of MEL was observed for the the HJ and VJ displayed no significant difference
subjective perception of sleep with a better quality between MEL and PLA conditions (p > 0.05).
8 M. CHEIKH ET AL.
Table 4. Mean ± SD values for short-term physical performances (n = 10) measured the following morning after nocturnal MEL or
PLA ingestion.
PLA MEL t value p value Δ value IC 95% ES
5-JT (m) 10.48 ± 0.68 10.56 ± 0.71 −3.18 p < 0.05 0.08 [−0.02 to 0.13] −0.11
HG (kg) 42.87 ± 5.86 43.65 ± 6.11 −0.78 p > 0.05 0.78 [−3.04 to 1.48] −0.13
HJ (cm) 217 ± 22,52 225 ± 14,14 −1.87 p > 0.05 8 [−1.61 to 17] −0.42
VJ (cm) 44.00 ± 7.36 44.3 ± 7.04 −0.58 p > 0.05 0.30 [−1.47 to 0.87] −0.41
PLA: placebo; MEL: melatonin; IC 95%: Confidence interval; ES: effect size; Δ = value MEL session–value PLA session; 5-JT: Five-jump test; HG: Hand-
grip strength; HJ: Horizontal jump; VJ: Vertical jump.
By referring to these studies, it seems of good awakening after sleep onset (NA) in healthy teen-
sense to admit that there was no negative impact agers (−36.73% compared with PLA). Accordingly,
of moderate late-evening exercise on sleep quality. Garfinkel et al. (1995) demonstrated that treatment
It seems, yet, to promote sleep. Therefore, we with 2 mg controlled release MEL for 3-weeks in
cannot evoke sleep problems following late-eve- MEL-deficient subjects significantly decreased the
ning moderate exercise. amount of awakening time after sleep onset.
According to Youngstedt (2005), sleep is dis- Similarly, Nave et al. (1995) found that MEL-5 mg
turbed if the exercise is performed in the four supplementation for a period of 4-weeks decreases
hours before sleep time. Likewise, exercise can NA in youngsters (6–17 years) with Autism
negatively affect the sleep quality when it was Spectrum Disorders.
performed close to bedtime (Stepanski and Wyatt Few studies have investigated the possible
2003). In this sense, Souissi et al. (2012) showed effects of exogenous MEL on sleep architecture.
that intense late-evening (at 20:00 h) exercise (i.e. The present study findings showed that MEL
YYIRT-1) disturbs sleep quality and quantity but decreased N1- and N2-sleep durations.
has no effect on sleep when performed in the Nonetheless, Wurtman and Zhdanova (1995) and
afternoon (at 14:00 h). Indeed, since we realized Monti et al. (1999) have found that the latter sleep
the present study in the perspectives of the study stages durations remained unchanged after admin-
of Souissi et al. (2012) done in the same laboratory istration of 2 or 3 mg of immediate-release MEL,
while keeping the same exhaustive exercise, our respectively.
first test session was performed late in the evening Regarding stage N3-sleep and REM-sleep, noctur-
(at ~20:00 h) namely ~2 hours before bed time. nal MEL-10 mg administration resulted in higher
sleep stages durations by 9.5 and 13.0%, respectively,
compared with PLA. These findings are in accor-
Results and discussion
dance with the results of Lewis (1999), showing that
The aim of this study was to investigate the effects a single dose of MEL-10 mg sharply increased both
of a single dose of MEL-10 mg ingestion after N3- and REM-sleep durations resulting in a restful,
exhaustive late-evening exercise on sleep quality regenerator and detoxifying sleep in healthy
and quantity, psycho-cognitive and short-term humans. In contrast, Hughes and Badia (1997)
physical performances the following morning in showed that sleep following a single dose of MEL-
young athletes. 10 mg administration among healthy young male
A major finding of this study was that nocturnal contained significantly more stage N2-sleep and
(i.e. 22:00 h) MEL ingestion significantly increased less N3-sleep, while stage N1-sleep and REM-sleep
TST and SE and lowered SOL. These results are were unaffected. However, previous study has shown
consistent with those of Smits et al. (2001) who that MEL had no effect on N2- and N3-sleep
showed that chronic (4-week 5 mg/day) MEL sup- (Almeida Montes et al. 2003). This discrepancy
plementation in adolescents improved SE, between the studies could be mainly explained by
increased TST and decreased SOL. Likewise, the divergences of the experimental protocols (i.e.
MEL was also successful in promoting TST and level of sleep deterioration, chronotype, age and sex
SE even when used as a treatment of sleep disorder of the participants and essentially the nature of MEL
in a particular population (children with neurolo- (double action, prolonged or immediate release cap-
gical disabilities, neuropsychiatric and develop- sules), the MEL dose and the time of MEL adminis-
ment including blindness, deaf-blindness, mental tration: daytime or nighttime administration). The
retardation and autism) (Jan and O’Donnell 1996) pooled data from various studies were highly hetero-
or in a pathological population (hypertensive geneous, possibly due to the fact that the MEL pre-
patients (Scheer et al. 2012), patients with chronic parations used in these individual studies varied in
primary insomnia (Monti et al. 1999)). dose used and probably also in quality, excipients
In the present study, nocturnal MEL-10 mg and purity as well (in this study, the MEL dose was
ingestion after intensive late-evening exercise characterized by a double action sustained release).
resulted in a significantly reduced nocturnal Thereby, when summarizing the effect of exogenous
10 M. CHEIKH ET AL.
MEL on sleep, it becomes apparent that nocturnal addition, the purpose of this study can respond to
administration of MEL improves sleep quality and the suggestion of Chase et al. (2017) who called for
quantity. Indeed, previous studies have shown that the search of strategies to improve the conse-
MEL is closely related to the beginning as well as the quences of sleep loss on performances the follow-
maintenance of sleep without altering its architec- ing morning which are shown to be impaired. In
ture (Gilbert et al. 1999). the present study and despite the same late-eve-
Concerning psycho-cognitive performances, the ning effort performed, MEL ingestion induced
present study’s findings showed that nocturnal several positive effects on sleep and short-term
MEL ingestion improved CRT and Vigilance physical and cognitive performances the following
(Zazzo Test) performances in the following morn- morning in comparison with PLA condition. The
ing. In fact, Zazzo test results indicated that noc- present findings showed that, whilst vertical and
turnal MEL-10 mg administration improved the horizontal jumps (VJ; HJ), Hand-grip strength
following day Speed and Performance of crossing (HG) and HRpeak did not change significantly
out a sign (Δ% = 26.5% and Δ% = 24.9%, respec- with nighttime MEL-10 mg ingestion, 5-JT,
tively) but had no effect on Inaccuracy, reflecting a YYIRT-1 and RPE were improved with MEL
better selective attention with MEL compared to dose quoted above. These findings are partially in
PLA. From a wellness prospective, the Hooper agreement with those of Atkinson et al. (2001)
index showed better scores of subjective sleep which concluded that MEL-5 mg ingested before
quality, fatigue and muscle soreness (with an aver- nocturnal sleep did not affect morning short-term
age change of 1.30; 1 and 1.30, respectively) the performances (i.e. HG; 4 km cycling) and RPE
morning after MEL ingestion compared with PLA. scores. There are obviously two differences
These findings are in accordance with those of between this study and the present work; the
Peck et al. (2004) concluding that MEL adminis- MEL dose used and the protocol setup (i.e.
tration at a dose of 1 mg nightly may be effective Atkinson et al.’s study was conducted without
in improving certain aspects of cognitive function- sleep disturbance). It seems, therefore, that 5 mg
ing and subjective reports of sleep quality in of MEL ingested before nocturnal exercise is not
healthy elderly subjects. Contrarily, Atkinson enough to exert a significant effect upon physical
et al. (2001) have shown that nocturnal (i.e. performance (Ghattassi et al. 2014). In addition,
23:00 h) MEL-5 mg administration had no effect Ghattassi et al. (2014) found a dose–response rela-
on subjective sleep quality and intra oral tempera- tionship between MEL and the effects on short-
ture in the following morning. Certainly, prolon- term evening physical performances. They showed
gation of sleep duration is also an indication of that although MEL-8 mg ingestion has an adverse
improved SE and continuity. Such improvements effect on physical capacities and 5-mg of MEL
are associated with better achievements in various ingestion does not affect short-term performances,
performance tests (such as attention, fine motor the measurement of the dependent variables was
activity and RT scores) and the sensation of before nocturnal sleep, and the latency between
improved well-being during the following day MEL administration and performance measures
(Satoh and Mishima 2001). Also, positive subjec- was shorter comparatively to the present study.
tive assessment of the levels of fatigue and muscles In addition, the present study was conducted
soreness could be explained by biochemical expla- during both exhaustive late-evening exercise con-
nations since MEL has many anti-inflammatory, dition and situation in which sleep is disturbed,
anti-oxidant, analgesic and nociceptive effects contrarily of the other studies that were released
(Escames et al. 2012). either before nocturnal sleep or in normal sleep
One of the reasons to conduct the present inves- situation.
tigation was the fact that the reliable data on the Finally, one of the strength of the present study
relationship between nighttime MEL ingestion is the use of PSG to evaluate and study sleep
after a late-evening exhaustive exercise and the among adolescent athletes. However, some limita-
following morning short-term physical perfor- tions inherent to the experimental protocol of this
mances are scarce particularly for adolescents. In study warrant mention. First, the sample size is
CHRONOBIOLOGY INTERNATIONAL 11
very small. Second, an experimental session with American Academy of Sleep Medicine. 2001. International
only MEL ingestion to dissociate the effect of the classification of sleep disorders, revised: diagnostic and
coding manual. Chicago (IL): American Academy of
exercise from that of MEL is missing. Third, the
Sleep Medicine.
use of an administration of a single dose of MEL- Atkinson G, Buckley P, Edwards B. 2001. Are there hangover
10 mg related to exhaustive late-evening exercise effects on physical performance when melatonin is
and adolescence limits the practical recommenda- ingested by athletes before nocturnal sleep? Int J Sports
tions from this study. Other possible limitations of Med. 22:232–34.
this study are summarized in the absence of some Babineau S, Goodwin C, Walker B. 2008. FPIN’s clinical
inquiries: medications for insomnia treatment in children.
necessary measures such as body temperature, as
Am Fam Physician. 77:358–59.
well as MEL and cortisol levels. Bastuji H, Jouvet M. 1985. Interret de l’agenda de sommeil
pour l’étude des troubles de la vigilance. Electroencephalogr
Clin Neurophysiol. 60:229–305.
Conclusion Beck WR, Botezelli JD, Rodrigo Pauli J, Ropelle ER, Gobatto
Both adolescence period and intensive evening CA. 2015. Melatonin has an ergogenic effect but does not
prevent inflammation and damage in exhaustive exercise.
exercises have been shown to affect sleep quality Sci Rep. 5:18065.
in teenagers. The present study showed that Bergeron MF, Mountjoy M, Armstrong N, Chia M, Côté J,
administration of a single dose of MEL-10 mg Emery CA, Faigenbaum A, Gary Hall Jr, Kriemler S,
after vigorous late-evening exercise could serve as Léglise M, et al. 2015. International Olympic committee
a pharmacological solution promoting sleep qual- consensus statement on youth athletic development. Br J
ity, cognitive performance, some short-term phy- Sports Med. 49:843–51.
Bleeker ML, Bolla-Wilson K, Agnew J, Meyers DA. 1987.
sical performances and wellness state the following Simple visual reaction time: sex and age differences. Dev
morning in teenage athletes. The present findings Neuropsychol. 3(2):165–72.
could be recommended only for short-term use in Borg GA. 1982. Psychophysical bases of perceived exertion.
teenagers since safety of long-term use of MEL has Med Sci Sports Exerc. 14:377–81.
not been well investigated in this age category. Bradford S, Fitzgerald A (2015). The impact of sleep on youth
athletic performance. Retrieved from: https://www.
researchgate.net/publication/282852030
Acknowledgments Brand S, Kirov R. 2011. Sleep and its importance in adoles-
cence and in common adolescent somatic and psychiatric
The authors wish to thank all participants for their voluntary conditions. Int J Gen Med. 4:425–42.
efforts and participation in this study. The authors wish to Brzezinski A. 1997. Melatonin in humans. N Engl J Med. 336
express their sincere gratitude to all the managers, specialists (3):186–95.
and technicians in the department of Functional Exploration Cain N, Gradisar M. 2010. Electronic media use and sleep in
of the Nervous system, CHU Sahloul, Sousse, Tunisia. school-aged children and adolescents: A review. Sleep
Med. 11:735–42.
Cavallo A. 1992. Plasma melatonin rhythm in normal pub-
Declaration of interest erty: interactions of age and pubertal stages. Neuroendoc.
55:372–79.
There are no conflicts of interest of the authors with the Chamari K, Chaouachi A, Hambli M, Kaouech F, Wisløff
information contained within the manuscript. U, Castagna C. 2008. The five-jump test for distance as a
field test to assess lower limb explosive power in soccer
players. J Strength Cond Res. 22:944–50.
ORCID Chase JD, Roberson PA, Saunders MJ, Hargens TA, Womack
Omar Hammouda http://orcid.org/0000-0002-5002-687X CJ, Luden ND. 2017. One night of sleep restriction following
Karim Chamari http://orcid.org/0000-0001-9178-7678 heavy exercise impairs 3-km cycling time trial performance
in the morning. Appl Physiol Nutr Metab. 42(9):909–15.
Cohen J. 1992. A power primer. Psychological Bulletin. 112
References (1):155–59.
Colrain IM, Baker FC. 2011. Changes in sleep as a function of
Almeida Montes LG, Ontiveros Uribe MP, Stores JC, Martin adolescent development. Neuropsychol Rev. 21:5–21.
GH. 2003. Treatment of primary insomnia with melatonin: Community Pediatrics Committee. 2012. Melatonin to treat
A double-blind, placebo controlled, crossover study. J sleep disorders in children and adolescents. Pediater Child
Psychiatry Neurosci. 28(3):191–96. Health. 17(6):33–46.
12 M. CHEIKH ET AL.
Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD. Monteleone P, Fuschino A, Nolfe G, Maj M. 1992.
1991. Delayed sleep phase syndrome response to melatonin. Temporal relationship between melatonin and cortisol
Lancet. 337:1121–24. responses to nighttime physical stress in humans.
De Quel OM, Bennett SJ, Lopez-Adan E, Zapico AG, Morales Psychoneuroendocrinology. 17(1):81–86.
FS. 2015. Choice reaction time is not related to competi- Monti JM, Alvariño F, Cardinali D, Savio I, Pintos A. 1999.
tion success in karate combat. Eur J Hum Move. 35:41–50. Polysomnographic study of the effect of melatonin on
Driver HS, Taylor SR. 2000. Exercise and sleep. Sleep Med sleep in elderly patients with chronic primary insomnia.
Rev. 4:387–402. Archof Geron and Geria. 28(2):85–98.
Dworak M, Wiater A, Alfer D, Stephan E, Hollmann W, Morin CM, Colecchi C, Stone J, Sood R, Brink D. 1999.
Struder HK. 2008. Increased slow wave sleep and reduced Behavioral and pharmacological therapies for late-lifeinsom-
stage 2 sleep in children depending on exercise intensity. nia: a randomized controlled trial. JAMA. 281(11):991–99.
Sleep Med. 9:266–72. Myllymäki T, Kyrolainen H, Savolainen K, Hokka L, Jakonen
Escames G, Ozturk G, Baño-Otálora B, Pozo MJ, Madrid R, Juuti T, Martinmäki K, Kaartinen J, Kinnunen
JA, Reiter RJ, Serrano E, Concepción M, Acuña- ML, Rusko H. 2011. Effects of vigorous late-night exercise
Castroviejo D. 2012. Exercise and melatonin in humans: on sleep quality and cardiac autonomic activity. J Sleep
reciprocal benefits. J Pineal Res. 52:1–11. Res. 20(1):146–53.
Garfinkel D, Laudon M, Nof D, Zisapel N. 1995. National Sleep Foundation. (2015). How much sleep do we
Improvement of sleep quality in elderly people by con- really need? Retrieved from: http://sleepfoundation.org/
trolled-release melatonin. Lancet. 346:541–44. how-sleep-works/how-much-sleep-do-we-really-need.
Ghattassi K, Graja A, Hammouda O, Chtourou H, Boudhina Nave R, Peled R, Lavie P. 1995. Melatonin improves evening
N, Chaouachi A, Souissi N. 2014. Effect of nocturnal napping. Eur J Pharmacol. 275:213–16.
melatonin ingestion on short-term anaerobic performance O’Connor PJ, Breus MJ, Youngstedt SD. 1998. Exercise-
in soccer players. Biol Rhy Res. 45(6):885–93. induced increase in core temperature does not disrupt a
Gilbert SS, Van Den Heuvel CJ, Dawson D. 1999. Daytime behavioral measure of sleep. Physiol Behav. 64:213–17.
melatonin and temazepam in young adult humans: Oliver SJ, Costa RJ, Laing SJ, Bilzon JL, Walsh NP. 2009. One
Equivalent effects on sleep latency and body temperatures. night of sleep deprivation decreases treadmill endurance
J Physiol (Lond). 514:905–14. performance. Eur J Appl Physiol. 107(2):155–61.
Harbard EB, Allen N, Trender J, Bei B. 2016. What’s keeping Owens JA. 2009. Pharmacotherapy of pediatric insomnia. J
teenagers up? Prebedtime behaviors and actigraphy- Am Acad Child Adolesc Psychiatry. 48:99–107.
assessed sleep over school and vacation. J Adolesc Peck JS, LeGoff DB, Ahmed I, Goebert D. 2004. Cognitive
Health. 58(4):426–32. effects of exogenous melatonin administration in elderly
Hauri P. 1968. Effects of evening activity on early night sleep. person: a pilot study. Am J Geriatr Psychiatry. 12(4):432–36.
Psychophysiology. 4:267–77. Reading P. 2013. ABC of sleep medicine. 1st ed. Oxford
Hooper SL, Mackinnon LT. 1995. Monitoring overtraining in (UK): John Wiley & sons, Ltd, p. 6.
athletes. Recommendations, Sports Med. 20:321–27. Roveda E, Sciolla C, Montaruli A, Calogiuri G, Carandente
Horne JA, Ostberg ON. 1976. Self-assessment questionnaire F, Sciolla C, Angeli A. 2011. Effects of endurance and
to determine morningness-eveningness in human circa- strength acute exercise on night sleep quality. Int
dian rhythms. Chronobiol Int. 4:97–110. Sportmed J. 12(3):113–24.
Hughes RJ, Badia P. 1997. Melatonin and sleep: sleep-pro- Satoh K, Mishima K. 2001. Hypothermic action of exogen-
moting and hypothermic effects of daytime melatonin ously administered melatonin is dosedependent in
administration in humans. Sleep. 20(2):124–31. humans. Clin Neuropharmacol. 24:334–40.
Jan JE, O’Donnell ME. 1996. Use of melatonin in the treat- Scheer FA, Morris CJ, Garcia JI, Smales C, Kelly EE, Marks J,
ment of pediatric sleep disorders. J Pineal Res. 21:193–99. Malhotra A, Shea SA. 2012. Repeated melatonin supple-
Kobayashi T, Yoshida H, Ishikawa T, Arakawa K. 1999. mentation improves sleep in hypertensive patients treated
Effects of the late evening exercise on sleep onset process. with Beta-Blockers: a randomized controlled trial. Sleep. 35
Sleep Res Online. 2(suppl. 1):233. (10):1395–402.
Krustrup P, Mohr M, Amstrup T, Rysgaard T, Johansen Shamseer L, Vohra S. 2009. Complementary, holistic, and
J, Steensberg A, Pedersen PK, Bangsbo J. 2003. The Yo- integrative medicine: melatonin. Pediatr Rev. 30(6):223.
Yo intermittent recovery test: physiological response, relia- Simpson NS, Gibbs EL, Matheson GO. 2016. Optimizing
bility, and validity. Med Sci Sports Exerc. 35(4):697–705. sleep to maximize performance: implications and recom-
Lang C, Brand S, Feldmeth AK, Holsboer-Trachsler E, Pühse mendations for elite athletes. Scand J Med Sci Sport. 27
U, Gerber M. 2013. Increased self-reported and objectively (3):266–74.
assessed physical activity predict sleep quality among ado- Smits MG, Nagtegaal EE, van der Heijden J, Coenen
lescents. Physiol and Behav. 120:46–53. AM, Kerkhof GA. 2001. Melatonin for chronic sleep
Lewis A. 1999. Melatonin and the biological clock. New onset insomnia in children: a randomized placebo con-
Canaan, CT: McGraw-Hill. ISBN 0-87983-734-739. trolled trial. J Child Neurol. 16(2):86–92.
CHRONOBIOLOGY INTERNATIONAL 13
Souissi M, Chtourou H, Zrane A, Ben Cheikh R, Dogui M, and high intensity interval training at two different times of
Tabka Z, Souissi N. 2012. Effect of time-of-day of aerobic day: a crossover study on the influence of the chronotype in
maximal exercise on the sleep quality of trained subjects. male collegiate soccer players. Chronobiology International.
Biol Rhythm Res. 43(3):323–30. 34(2):260–68.
Souissi N, Chtourou H, Aloui A, Hammouda O, Dogui Vitale JA, Weydahl A. 2017. Chronotype, physical activity,
M, Chaouachi A, Chamari K. 2013. Effects of time-of-day and sport performance: a systematic review. Sports
and partial sleep deprivation on short-term maximal per- Medicine. 47(9):1859–68.
formances of judo competitors. J Strength Cond Res. 27 Vyazovskiy VV, Delogu A. 2014. NREM and REM sleep:
(9):2473–80. complementary roles in recovery after wakefulness.
Stepanski EJ, Wyatt JK. 2003. Use of sleep hygiene in the Neuroscientist. 20:203–19.
treatment of insomnia. Sleep Med Rev. 7:215–25. Wurtman RJ, Zhdanova I. 1995. Improvement of sleep qual-
Strasburger V, Hogan M. 2013. Policy statement: children, ity by melatonin. Lancet. 346:14–19.
adolescent, and the media. Pediatrics. 132:958–61. Young W. 1995. A simple method for evaluating the strength
Szeinberg A, Borodkin K, Dagan Y. 2006. Melatonin treat- qualities of the leg extensor muscles and jumping abilities.
ment in adolescents with delayed sleep phase syndrome. Strength Conditioning Coach. 2(4):5–8.
Clin Pediatr (Phila). 45:809–18. Youngstedt SD. 2005. Effects of exercise on sleep. Clin Sorts
Tanner J, Whitehouse R. 1976. Clinical longitudinal stan- Med. 24:355–65.
dards for height, weight, height velocity and the stages of Youngstedt SD, Kripke DF, Elliott JA. 1999. Is sleep disturbed
puberty. Arch Dis Child. 51:170–79. by vigorous late-night exercise? Med Sci Sports Exerc. 31
Tavernier R, Choo SB, Grant K, Adam EK. 2016. Daily (6):864–69.
affective experiences predict objective sleep outcomes Youngstedt SD, O’Connor PJ, Crabbe JB, Dishman RK. 2000.
among adolescents. J Sleep Res. 25:62–69. The influence of acute exercise on sleep following high
Taylor L, Chrismas BCR, Dascombe B, Chamari K, Fowler caffeine intake. Physiol Behav. 68:563–70.
FP. 2016. The importance of monitoring sleep within Youngstedt SD, O’Connor PJ, Dishman RK. 1997. The effects
adolescent athletes: athletic, academic, and health consid- of acute exercise on sleep: a quantitative synthesis. Sleep.
erations. Front Physiol. 7:101. 20:203–14.
Thun E, Bjorvatn B, Flo E, Harris A, Pallesen S. 2015. Sleep, Zazzo R. 1969. Le test des deux barrages. In Zazzo R, ed.
circadian rhythms, and athletic performance. Sleep Med Manuel pour l’examen psychologique de l’enfant.
Rev. 23:1–9. Neufchatel (France): Delachaux et Niestlé; p. 470–575.
Vitale JA, Bonato M, Galasso L, La Torre A, Merati Zhdanova IV, Wurtman RJ. 1997. Efficacy of melatonin as a
G, Montaruli A, Roveda E, Carandente F. 2017. Sleep quality sleep-promoting agent. J of Biol Rhyth. 112:644–50.